Comparative Effects on Fetal Hematopoiesis and Placental Inflammation From Mesenchymal and Hematopoietic Stem Cells as Agents of Transamniotic Stem Cell Therapy (TRASCET) in a Syngeneic Model of Intrauterine Growth Restriction

In brief

This study evaluates two stem cell approaches for treating intrauterine growth restriction via transamniotic delivery, comparing mesenchymal versus hematopoietic stem cells. The research examines therapeutic effects on fetal blood cell development and placental inflammatory responses in a controlled animal model.

Written by the GCMD Library team from the article.